Latest News about IONS
Recent news which mentions IONS
Ionis Posts Surprise Q2 Profit, Double Revenues On Stronger Sales From Newly Approved Genetic Disease Drug
July 30, 2025
From Benzinga
Earnings Scheduled For July 30, 2025
July 30, 2025
From Benzinga
From Benzinga
Biogen-Ionis Partnered Drug Shows Benefit In Children With Spinal Muscular Atrophy Previously Treated With Novartis' Zolgensma
June 25, 2025
From Benzinga
From Benzinga
Earnings Scheduled For April 30, 2025
April 30, 2025
From Benzinga
From Benzinga
This Reddit Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
April 07, 2025
From Benzinga
Ionis Pharmaceuticals Partners With Japan-Based Ono Pharmaceutical For Rare Blood Disease Drug In Over $800 Million Deal
March 12, 2025
From Benzinga
What Analysts Are Saying About Ionis Pharmaceuticals Stock
March 11, 2025
Tickers
IONS
From Benzinga
What Analysts Are Saying About Ionis Pharmaceuticals Stock
February 20, 2025
Tickers
IONS
From Benzinga
Ionis Pharmaceuticals Q4 Revenue Growth Exceeds Guidance, Forecasts Over $600 Million In 2025 Sales
February 19, 2025
From Benzinga
Earnings Scheduled For February 19, 2025
February 19, 2025
From Benzinga
The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 5 Experts
January 15, 2025
Tickers
IONS
From Benzinga
Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected
January 07, 2025
From Benzinga
From Benzinga
The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 6 Experts
December 20, 2024
Tickers
IONS
From Benzinga
FDA Approves Ionis Pharmaceuticals' Rare Genetic Disease Therapy to Lower High-Level Of Fat In Blood
December 20, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 12, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.